[Prophylaxis of infectious complications by selective digestive bacterial decontamination in patients with cirrhosis].
Grangé
J D
JD
Service d'Hépato-Gastroentérologie, Hôpital Tenon, Paris.
Amiot
X
X
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001202:Ascitic Fluid / Q000209:etiology / Q000382:microbiology / Q000517:prevention & control; D001424:Bacterial Infections / Q000209:etiology / Q000517:prevention & control*; D003666:Decontamination / Q000379:methods*; D004066:Digestive System Diseases / Q000209:etiology / Q000382:microbiology / Q000517:prevention & control*; D004756:Enterobacteriaceae Infections / Q000209:etiology / Q000517:prevention & control; D006471:Gastrointestinal Hemorrhage / Q000150:complications; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications*; D016031:Liver Transplantation / Q000009:adverse effects; D009643:Norfloxacin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D009643:Norfloxacin
La prophylaxie des complications infectieuses par décontamination bactérienne digestive sélective chez les malades atteints de cirrhose.